Land: Bandaríkin
Tungumál: enska
Heimild: NLM (National Library of Medicine)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP)
Physicians Formula, Inc.
TITANIUM DIOXIDE
TITANIUM DIOXIDE 12 g in 100 g
TOPICAL
OTC DRUG
OTC monograph final
SUPER BB INSTAREADY FILTER TRIO BB POWDER- TITANIUM DIOXIDE POWDER PHYSICIANS FORMULA, INC. _Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they_ _comply with applicable regulations and policies. FDA has not evaluated whether this product complies._ ---------- SUPER INSTAREADY BB POWDER_PF-ART Principle Display Panel SUPER BB INSTAREADY FILTER TRIO BB POWDER titanium dioxide powder PRODUCT INFORMATION PRODUCT T YPE HUMAN OTC DRUG ITE M CODE (SOURCE ) NDC:316 45-19 0 ROUTE OF ADMINISTRATION TOPICAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH TITANIUM DIO XIDE (UNII: 15FIX9 V2JP) (TITANIUM DIOXIDE - UNII:15FIX9 V2JP) TITANIUM DIOXIDE 12 g in 10 0 g Physicians Formula, Inc. INACTIVE INGREDIENTS INGREDIENT NAME STRE NG TH TALC (UNII: 7SEV7J4R1U) CALCIUM ALUMINUM BO RO SILICATE (UNII: 3JRB8 A35M0 ) LAURO YL LYSINE (UNII: 113171Q70 B) DIMETHICO NE 2 0 0 (UNII: RGS4T2AS0 0 ) BUTYLENE GLYCO L (UNII: 3XUS8 5K0 RA) TRIETHO XYCAPRYLYLSILANE (UNII: LDC331P0 8 E) PHENO XYETHANO L (UNII: HIE49 2ZZ3T) ALUMINUM CHLO RO HYDRATE (UNII: HPN8 MZW13M) MICA (UNII: V8 A1AW0 8 8 0 ) ETHYLHEXYLGLYCERIN (UNII: 147D247K3P) DEHYDRO ACETIC ACID (UNII: 2KAG279 R6 R) NYLO N-12 (UNII: 446 U8 J0 75B) PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:316 45-19 0 -0 2 1 in 1 CARTON 0 1/0 1/20 16 12/31/20 19 1 NDC:316 45-19 0 -0 1 11 g in 1 PACKAGE; Type 0 : No t a Co mbinatio n Pro duct MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITATION MARKE TING START DATE MARKE TING END DATE OTC mo no graph final pa rt352 0 1/0 1/20 16 12/31/20 19 LABELER - Physicians Formula, Inc. (021261805) Revised: 12/2019 Lestu allt skjalið